Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (192${count})

  • Parkinson’s Disease Therapeutics Pipeline Program, 2024
    Use of an Angiotensin-(1-7) Glycopeptide, to Treat Dementia in Parkinson's Disease

    Study Rationale: Peptide-based drugs are attractive candidates for treating the cognitive decline associated with Parkinson’s disease (PD) because they demonstrate a robust safety profile and an...

  • , 2022
    Studying the Epidemiology of Parkinson’s Disease in Latin America: Learning from Underrepresented Populations

    Study Rationale: Initial evidence has shown that the global distribution of Parkinson’s disease (PD) may vary; however, little is known about the prevalence of PD across large parts of the world. This...

  • Research Grant, 2016
    Tau Imaging in Parkinson's Disease

    Study Rationale:
    A substantial proportion of individuals with Parkinson's disease develop cognitive
    impairment, or difficulty with thinking abilities. The basis for these changes is poorly
    understood. We...

  • Translational Pipeline Program, 2022
    Prevention of Dementia in GBA-associated Parkinson’s Disease

    Study Rationale: Whereas motor symptoms can be well controlled by dopamine-enhancing drugs and deep brain stimulation, dementia represents a key milestone in the course of Parkinson’s disease (PD)...

  • Research Grant, 2017
    Blood Proteins for the Treatment of Parkinson’s Disease

    Study Rationale & Design:
    Components of blood have been found to improve health and enhance multiple biological functions in pre-clinical studies of age-related decline. Blood plasma has been...

  • Improved Biomarkers and Clinical Outcome Measures, 2019
    Mitochondrial Complex 1 PET Imaging in Parkinson’s Disease

    Study Rationale:
    Methods are needed for imaging early pathological changes in the brain. With such brain imaging, we would be able to determine whether medications are protecting against progression...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.